Cargando…
Presumed LRP1-targeting transport peptide delivers β-secretase inhibitor to neurons in vitro with limited efficiency
Interfering with the activity of β-secretase to reduce the production of Aβ peptides is a conceivable therapeutic strategy for Alzheimer’s disease. However, the development of efficient yet safe inhibitors is hampered by secondary effects, usually linked to the indiscriminate inhibition of other sub...
Autores principales: | Kim, Jong Ah, Casalini, Tommaso, Brambilla, Davide, Leroux, Jean-Christophe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041153/ https://www.ncbi.nlm.nih.gov/pubmed/27682851 http://dx.doi.org/10.1038/srep34297 |
Ejemplares similares
-
A lipid boundary separates APP and secretases and limits amyloid β-peptide generation
por: Kaether, Christoph, et al.
Publicado: (2004) -
LRP1 Downregulates the Alzheimer’s β-Secretase BACE1 by Modulating Its Intraneuronal Trafficking1,2,3
por: Tanokashira, Daisuke, et al.
Publicado: (2015) -
Topographic distinction in long-term value signals between presumed dopamine neurons and presumed striatal projection neurons in behaving monkeys
por: Enomoto, Kazuki, et al.
Publicado: (2020) -
Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
por: Schedin-Weiss, Sophia, et al.
Publicado: (2017) -
LRP-1 and LRP-2 receptors function in the membrane neuron. Trafficking mechanisms and proteolytic processing in Alzheimer's disease
por: Spuch, Carlos, et al.
Publicado: (2012)